reported that the serum M30 and M65 levels in patients with colorectal cancer are associated with disease stages and tumor burden, and the ratio of cleaved K18/total K18 decreased with tumor progression, indicating increased tumor necrosis and worse progression-free survival (156). This evidence concerns the gene KRT18 and neoplasm.